Date: December 10, 2025 – Market close snapshot
Synopsys, Inc. (NASDAQ: SNPS) heads into a pivotal evening on Wednesday as investors brace for fourth‑quarter and full‑year fiscal 2025 results, just days after Nvidia revealed a $2 billion equity stake and expanded AI partnership in the chip‑design software giant. At today’s close, Synopsys shares traded around $468, up about 0.5% versus yesterday’s close of $465.85, modestly outperforming a mostly flat U.S. equity market ahead of a key Federal Reserve decision.
The stock remains well below its 52‑week high near $652, but comfortably above its 52‑week low around $366, reflecting a year that has combined transformative M&A, a major AI partnership, an earnings stumble, and now a wave of shareholder lawsuits.
Synopsys stock price and valuation snapshot
- Price (Dec 10, 2025, near close): ~$468 per share
- Yesterday’s close (Dec 9): $465.85
- 52‑week range: $365.74 – $651.73
On most recent data, Synopsys trades at roughly 36–37x trailing earnings, with a price‑to‑sales ratio around 11 and price‑to‑book near 3.1, placing it firmly in “quality growth at a high multiple” territory. GuruFocus+1
Institutional investors dominate the shareholder base: filings suggest over 85% of Synopsys stock is held by institutions and hedge funds.
Nvidia’s $2 billion stake: a structural AI partnership
The biggest strategic development around Synopsys this month is Nvidia’s decision to take a $2 billion equity stake as part of an expanded, multi‑year partnership to “re‑engineer engineering” using GPU‑accelerated computing and AI. Synopsys News Releases+1
Key points from the deal:
- Nvidia invested $2 billion in Synopsys common stock at $414.79 per share.
- The partnership spans CUDA‑accelerated computing, “agentic” AI, AI physics and Omniverse‑based digital twins, targeting workloads from chip design to aerospace, automotive, industrial and more. Synopsys News Releases+1
- Synopsys will optimize a wide range of EDA and simulation tools for Nvidia GPUs, including chip design, physical verification, molecular and electromagnetic simulation and other compute‑intensive domains.
- The relationship is explicitly non‑exclusive: Synopsys reiterates it will continue to work with other semiconductor vendors such as AMD and Intel.
At today’s market price, Nvidia’s stake is already roughly 13% in the black compared with its entry price, underscoring how quickly the market repriced Synopsys after the announcement. (That gain is an unrealized mark‑to‑market figure, not a realized profit.)
Analyst commentary from 24/7 Wall St describes the move as a “smart deal” that highlights electronic design automation (EDA) providers like Synopsys as a sweet spot for AI monetization, coming after the stock had fallen roughly 25% from its peak earlier in 2025. 24/7 Wall St.
For long‑term holders, the Nvidia tie‑up reinforces the idea that Synopsys is evolving from a niche design‑tool vendor into critical AI infrastructure for the semiconductor and broader engineering ecosystem.
Q4 fiscal 2025 earnings tonight: expectations and context
Synopsys will report fourth‑quarter and full‑year fiscal 2025 results after today’s closing bell, followed by an earnings call at 2:00 p.m. Pacific / 5:00 p.m. Eastern.
Management guidance vs Street expectations
In its September Q3 earnings release, Synopsys guided for:
- Q4 FY25 revenue: $2.23–$2.26 billion
- Q4 non‑GAAP EPS: $2.76–$2.80
- Full‑year FY25 revenue: $7.03–$7.06 billion
- Full‑year non‑GAAP EPS: $12.76–$12.80
By contrast, Wall Street consensus compiled by Benzinga currently expects:
- Q4 EPS: about $2.88, down from $3.40 in the prior‑year quarter
- Q4 revenue: around $2.24 billion, up from $1.64 billion a year earlier
That suggests analysts are looking for Synopsys to come in slightly above its own EPS midpoint and roughly in line with revenue guidance.
Q3 “transformational” quarter, but with a miss
Q3 FY25, reported in September, was described by management as a “transformational quarter” because Synopsys: PR Newswire
- Completed its acquisition of Ansys on July 17, 2025, bringing world‑class simulation and multiphysics tools into the fold.
- Delivered revenue of $1.74 billion, up 14% year‑over‑year.
- Reported GAAP EPS of $1.50 and non‑GAAP EPS of $3.39.
However, those results missed Street expectations of roughly $1.77 billion in revenue and $3.75 in EPS, and the company lowered its outlook, chiefly due to weakness in its Design IP segment and a more cautious stance on China‑related demand.
That earnings miss and guidance cut triggered a sharp sell‑off which, according to later legal filings, contributed to an approximately 35% decline from earlier 2025 highs.
Tonight’s call is therefore critical: investors will want clarity on
- Recovery in Design IP,
- Early revenue and margin impact from the Ansys integration, and
- How quickly Nvidia‑accelerated tools and agentic‑AI workflows can translate into tangible growth.
Analyst ratings and price targets: “Moderate Buy” with mid‑teens upside
Despite the volatility, the analyst community remains broadly constructive on Synopsys.
Consensus view
MarketBeat data shows that, over the last 12 months:
- 18 Wall Street analysts cover SNPS.
- Ratings mix: 11 Buy, 6 Hold, 1 Sell.
- Consensus rating: “Moderate Buy.”
- Average 12‑month price target:$550.67.
- Target range: low of $425 to high of $630.
That average target implies roughly 17–18% upside from current levels near $468–469.
Public.com’s aggregated data, based on 15 analysts, similarly shows a consensus “Buy” rating and the same $550.67 average price target. Public
Recent upgrades and downgrades
Several key rating changes frame today’s sentiment:
- Rosenblatt Securities upgraded Synopsys to Buy from Neutral on December 9, 2025, while trimming its target from $605 to $560.
- Citi recently upgraded Synopsys to Neutral from Underperform ahead of Q4 results, signalling that at least one previously bearish house sees downside as more limited after the stock’s pullback.
- Earlier in the year, firms including Morgan Stanley, JPMorgan, Needham, Piper Sandler and Bank of America reduced price targets following the Q3 miss and guidance cut, even as most maintained Overweight or Buy ratings.
A GuruFocus analysis pegs Synopsys at a P/E of ~36.45, P/S of 11.38, P/B of 3.12 and an Altman Z‑Score of 3.16, indicating solid balance‑sheet health. It also notes high institutional ownership (~92%) and quantitative risk measures such as a low Piotroski F‑Score and a Beneish M‑Score that warrants monitoring.
In short, Wall Street largely still sees Synopsys as a high‑quality, AI‑leveraged compounder trading at a premium multiple, with recent target cuts reflecting near‑term earnings and execution risk rather than a broken long‑term thesis.
Institutional activity: State Street adds, Axa trims
Recent 13F filings reveal notable shifts among large shareholders:
- State Street Corp increased its stake by 1.2% in Q2, bringing holdings to 7,266,446 shares, or about 4.68% of Synopsys, worth approximately $3.73 billion at the time of filing.
- A separate filing shows Axa S.A.cut its SNPS holdings by 38.9%, selling 36,565 shares and ending the quarter with 57,389 shares valued around $29.4 million.
Collectively, filings indicate that institutional investors hold more than 85% of Synopsys’ float, a high level of professional ownership that tends to amplify both downside and upside moves around major news events like tonight’s earnings release.
Legal overhang: class‑action investigations after a 35% drop
On December 9–10, multiple plaintiff law firms announced securities‑fraud class‑action investigations related to Synopsys.
Key elements:
- Faruqi & Faruqi LLP is soliciting investors who bought Synopsys shares between December 4, 2024 and September 9, 2025, highlighting a December 30, 2025 deadline to seek lead‑plaintiff status.
- Kahn Swick & Foti (KSF) similarly reminds investors with “substantial losses” of the same deadline, referring to a class action alleging undisclosed financial problems and an approximate 35% stock decline. GlobeNewswire
These notices are attorney advertisements, not court findings. The allegations have not been adjudicated, and Synopsys’ formal legal response was not included in the materials reviewed. Nonetheless, the cases introduce headline and litigation risk that investors will weigh alongside the company’s growth story.
AI, Ansys and “agentic AI”: the long‑term growth narrative
Beyond the week‑to‑week stock moves, Synopsys has spent 2025 deepening its identity as an AI‑first engineering platform.
Expanded Synopsys.ai Copilot and GenAI tools
In September, the company announced expanded Synopsys.ai Copilot capabilities across its semiconductor design tools, including:
- GenAI assistants that cut documentation search and script generation from hours to minutes,
- A “workflow assistant” that can double script‑development speed and generate certain PrimeTime scripts 10–20x faster, and
- Reports from early customers of roughly 30% faster ramp time for junior engineers and meaningful boosts in productivity for experienced staff.
Synopsys is also integrating Ansys Engineering Copilot and Ansys SimAI into its portfolio, combining AI with physics‑accurate simulation to accelerate design‑space exploration across industries from semiconductors to automotive and industrial systems.
Agentic AI and GPU‑accelerated simulation
At NVIDIA GTC Washington, D.C. in October, Synopsys showcased agentic AI—multi‑agent systems built to autonomously perform portions of chip‑design and verification workflows.
Highlights from that event and related releases:
- Synopsys is combining AgentEngineer™ with Nvidia’s NeMo agent toolkit and Nemotron models to create more autonomous design flows.
- GPU‑accelerated tools, including Ansys Fluent, have demonstrated up to 500x speed‑ups in certain simulations when run on Nvidia GPUs, with AI‑enhanced initialization delivering order‑of‑magnitude additional efficiency gains.
- Materials‑simulation workloads using Synopsys QuantumATK integrated with Nvidia’s CUDA‑X stack can see up to 15x faster time‑to‑results, supporting faster innovation in semiconductor materials.
Combined with the Ansys acquisition, these initiatives position Synopsys as a full “silicon‑to‑systems” engineering platform, with AI and GPU acceleration embedded across design, verification, simulation and digital‑twin workflows. PR Newswire+1
Macro backdrop: cautious tape ahead of the Fed
Synopsys’ earnings also land into a macro environment that’s far from boring. Mid‑day Wednesday, the S&P 500 was modestly lower and the Nasdaq 100 down about 0.5% as investors waited for the Federal Reserve’s latest decision and Chair Jerome Powell’s comments.
Bond yields touched multi‑month highs earlier in the session before easing, and futures markets were pricing in a 25‑basis‑point rate cut paired with “hawkish” guidance—a combination that tends to weigh on higher‑multiple growth stocks if the Fed signals a long pause on further cuts. FinancialContent
For a name like Synopsys, with a premium valuation and AI‑driven growth story, Fed tone and rate expectations remain an important secondary driver of near‑term share performance.
Key risks and catalysts to watch
Near‑term catalysts
- Q4 FY25 results and FY26 outlook (tonight):
- EPS/revenue relative to both guidance and consensus.
- Any commentary on the sustainability of Design Automation growth vs. IP weakness.
- Updated synergy and integration roadmap for Ansys.
- Details on Nvidia partnership monetization:
- Timeline for GPU‑accelerated tools to contribute meaningfully to revenue.
- Joint go‑to‑market plans across non‑semiconductor verticals.
- Legal developments:
- Progress of class‑action suits and any early rulings or settlements.
Key risks
- Integration risk around the Ansys acquisition and execution on a complex, physics‑plus‑electronics roadmap.
- Geopolitical and export‑control risk, especially related to China, which management has already cited as a headwind.
- Litigation and reputational risk linked to ongoing securities‑fraud allegations.
- Valuation risk if growth moderates or the Fed remains tighter for longer, compressing multiples across high‑growth tech.
Bottom line
On December 10, 2025, Synopsys stock is trading modestly higher into a densely packed news day:
- Nvidia’s $2 billion equity stake and deep AI partnership strengthens the long‑term narrative that Synopsys is core infrastructure for AI‑enabled chip and system design.
- Q4 and full‑year results tonight will test whether management can stabilize growth after a Q3 miss and guidance cut.
- Class‑action investigations add a legal overhang but are still in early stages.
- Wall Street maintains a Moderate‑to‑Buy consensus with average targets pointing to mid‑teens upside over the next 12 months.
